☆ 4.5 Article

Non-cardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG-HF trial

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial

Marianna Adamo et al.

Summary: The STRONG-HF study found that rapid up-titration of GRMT in a high intensity care strategy can improve outcomes in patients with acute HF. This study aimed to evaluate the role of NT-proBNP in early treatment. The results showed that regardless of baseline NT-proBNP levels, HIC was associated with a reduced risk of 180-day HF readmission or death compared to usual care.

EUROPEAN HEART JOURNAL (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trial

Kamile Cerlinskaite-Bajore et al.

Summary: The study aimed to evaluate the effectiveness and safety of rapid up-titration of guideline-directed medical therapies (GDMT) in men and women hospitalized for acute heart failure (AHF). The high-intensity care (HIC) strategy of GDMT up-titration resulted in a higher proportion of both men and women reaching full doses compared to usual care (UC). There were no significant differences in outcomes, quality of life improvement, or adverse events between sexes.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trial

Mattia Arrigo et al.

Summary: Aims STRONG-HF investigated the efficacy and safety of high-intensity care (HIC) strategy after acute heart failure (AHF) admission and evaluated the impact of age. The study found that HIC significantly reduced the 180-day death or HF readmission rate in patients of different age groups, but had smaller effects on improving the quality of life in older patients.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction

Matteo Pagnesi et al.

Summary: This study demonstrates that a strategy of rapid uptitration of oral treatment for heart failure and close follow-up, compared with usual care, can significantly improve the prognosis of patients with acute heart failure, regardless of left ventricular ejection fraction. This approach reduces the risk of HF rehospitalization or all-cause death within 180 days after AHF hospitalization, independently of LVEF.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry

Ovidiu Chioncel et al.

Summary: This study investigates the prevalence and associations of non-cardiac comorbidities (NCCs) with in-hospital and post-discharge outcomes in acute heart failure (AHF) patients with different ejection fraction (EF) categories. Multiple NCCs are associated with poor outcomes, and the association between individual comorbidities and post-discharge outcomes varies among different EF categories, suggesting the need for specific multidisciplinary management programs for different comorbidities in post-discharge phase.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

Theresa A. McDonagh et al.

Summary: All experts involved in the development of the guidelines have declared their interests, and the declarations have been compiled and published in a supplementary report. The report can be accessed on the ESC website. The supplementary data provide background information and detailed discussion of the data that form the basis for the guidelines.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction

Daniela Tomasoni et al.

Summary: Sodium-glucose co-transporter 2 (SGLT2) inhibitors are recommended for the treatment of heart failure patients due to their favorable effects. These drugs can be administered early in the treatment process to reduce clinical events and improve quality of life, and their efficacy is independent of background therapy.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Multimorbidity, guideline-directed medical therapies, and associated outcomes among hospitalized heart failure patients

Shinsuke Takeuchi et al.

Summary: This study examined the prevalence of multimorbidity clusters and the impact of guideline-directed medical therapy (GDMT) on the prognosis of heart failure (HF) patients. The results showed that the presence of comorbidity clusters was associated with poorer outcomes, but GDMT remained beneficial in reducing adverse outcomes.

ESC HEART FAILURE (2022)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Timing of Statistical Benefit of Mineralocorticoid Receptor Antagonists Among Patients With Heart Failure and Post-Myocardial Infarction

Wassim Bedrouni et al.

CIRCULATION-HEART FAILURE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities

Nancy M. Albert et al.

Summary: In HFrEF patients, those with comorbidities were less likely to use ACEi/ARB/ARNI, while patients with obstructive sleep apnea were more likely to be prescribed ARNI and MRA. Patients with atrial fibrillation were less likely to receive ACEi/ARB and any study medication.

AMERICAN HEART JOURNAL (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Temporal trends in mortality and readmission after acute heart failure: a systematic review and meta-regression in the past four decades

Antoine Kimmoun et al.

Summary: This study analyzed AHF studies with more than 100 patients from 1980 to 2017 and found a declining trend in 30-day all-cause death rates, although mortality and readmission rates remained high. The increase in the use of oral neurohormonal antagonists may be associated with improved survival after AHF episodes.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Simultaneous or Rapid Sequence Initiation of Quadruple Medical Therapy for Heart Failure-Optimizing Therapy With the Need for Speed

Stephen J. Greene et al.

Summary: This viewpoint argues for increased use of quadruple therapy in patients with heart failure with reduced ejection fraction, emphasizing the importance of this approach in managing the condition effectively.

JAMA CARDIOLOGY (2021)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Amended STRONG-HF study design

Gad Cotter et al.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Sacubitril/Valsartan Initiation and Postdischarge Adherence Among Patients Hospitalized for Heart Failure

Anthony P. Carnicelli et al.

Summary: The study found that over 90% of eligible HFrEF patients were discharged without sacubitril/valsartan in US clinical practice from 2015 to 2017. Patients initiated with sacubitril/valsartan as inpatients had better postdischarge medication adherence compared to those initiated at discharge. Patients who were not prescribed sacubitril/valsartan upon discharge were unlikely to receive it during follow-up.

JOURNAL OF CARDIAC FAILURE (2021)

Add to Collection

Article Medicine, General & Internal

Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial

Phillip H. Lam et al.

AMERICAN JOURNAL OF MEDICINE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HF

Ankeet S. Bhatt et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP and GDF-15, of Heart Failure therapies (STRONG-HF): rationale and design for a multicentre, randomized, parallel-group study

Antoine Kimmoun et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease

Marco Canepa et al.

JACC-HEART FAILURE (2019)

Add to Collection

Article Medicine, General & Internal

Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure

Eric J. Velazquez et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease

Iris E. Beldhuis et al.

JACC-HEART FAILURE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction

Tetsuo Yamaguchi et al.

AMERICAN JOURNAL OF CARDIOLOGY (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction

Koen W. Streng et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

Multimorbidity in Older Adults With Cardiovascular Disease

Daniel E. Forman et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure

Kevin Damman et al.

JACC-HEART FAILURE (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial

Soren L. Kristensen et al.

CIRCULATION-HEART FAILURE (2016)

Add to Collection

Article Medicine, General & Internal

Beta-blocker therapy and prognosis of heart failure patients with new-onset diabetes mellitus

A. Garcia-Egido et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey

Vincent M. van Deursen et al.

EUROPEAN JOURNAL OF HEART FAILURE (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction

Hannah Clark et al.

EUROPEAN JOURNAL OF HEART FAILURE (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure

Lesley H. Curtis et al.

AMERICAN HEART JOURNAL (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association of Beta-Blocker Use and Selectivity With Outcomes in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease (from OPTIMIZE-HF)

Robert J. Mentz et al.

AMERICAN JOURNAL OF CARDIOLOGY (2013)

Add to Collection

Review Cardiac & Cardiovascular Systems

Heart Failure and Chronic Obstructive Pulmonary Disease

Nathaniel M. Hawkins et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)

Add to Collection

Article Cardiac & Cardiovascular Systems

Differences Between Beta-Blockers in Patients With Chronic Heart Failure and Chronic Obstructive Pulmonary Disease A Randomized Crossover Trial

Andrew Jabbour et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Add to Collection

Article Medicine, General & Internal

Effects of initiating carvedilol in patients with severe chronic heart failure - Results from the COPERNICUS study

H Krum et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.